Columbia Care to Redeploy Capital, Enhance Liquidity

Pending a megamerger agreement with Cresco Labs, Columbia Care is focusing on current markets that are driving the most value.

Inside Columbia Care's cannabis dispensary in Deptford, N.J.
Courtesy of Columbia Care

Columbia Care

Company Profile: 

Headquarters: New York, N.Y.

Operating States: 15 states and Washington, D.C. 

Employees: ≈ 2,600

Dispensaries: 85 

Cultivation Sites: 32 

Cultivation/Production Capacity: ≈ 2 million square feet

Outdoor Cultivation Capacity: 150+ acres

Geographic Focus: Prioritizing markets that are driving profitability and growth, particularly East Coast markets, including New Jersey, Virginia and West Virginia.

Q1 2023 Financial Highlights:

  • Net Revenue: $124.5 million 
  • Gross Profit: $47.1 million (gross margin of 38%)
  • Net Loss: $36.6 million 
  • Cash Balance: $40.2 million 

States With Retail Operations: Arizona (2), California (5), Colorado (23), D.C. (1), Delaware (3), Florida (14), Illinois (2), Massachusetts (3), Maryland (3), New Jersey (2), New York (4), Ohio (5), Pennsylvania (3), Utah (1), Virginia (9), West Virginia (5)

Brands: Cannabist (retail brand), Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, Amber

2023 Expansion Highlights:

  • Opened three stores in Virginia and one store in West Virginia 
  • Sold Missouri operations, closed three unprofitable retail locations in Colorado and one in California
  • Consolidated cultivation operations in California, Colorado and Pennsylvania to improve adjusted EBIDA contribution
  • Launched adult-use cannabis sales July 1 at three retail locations in Maryland
  • Anticipating the close of the Cresco Labs transaction 

Commentary:

Nicholas Vita, CEO, Columbia Care, on the company’s first quarter 2023 earnings call: “We’ve made the decision to focus on the markets that are really driving the most value. I think our strategy, up until the restructuring was announced, was to have our fingers in a lot of pots. And that has served us well. But at this point, especially in the context of the Cresco merger, we’re not in a position to go out and continue to scale into a lot of these markets, so we really need to focus on the markets where we already have scaled. Thankfully, we have enormous scale in a number of very meaningful markets that are providing us with a very attractive runway going forward. So, when you look at a market like Missouri, the decision to exit was as much about driving profitability and margins as it was to do a relative value assessment: Where are we going to be able to either redeploy that capital or enhance liquidity to improve our overall performance? So, we don’t have a lot of assets like that, but whatever assets in the portfolio that remain can certainly fall under that bucket if we pushed in that direction.”